File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Conventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma.

TitleConventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma.
Authors
KeywordsCirculating tumor cells
ct DNA
Diagnosis
EBV BART miRNAs
EBV serology
Issue Date2019
PublisherAcademic Press.
Citation
Conventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma.. In Lee, A., Lung, M and Ng, W. (Eds.), Nasopharyngeal Carcinoma: Etiology to Clinical Practice, p. 129-153. London: Academic Press., 2019 How to Cite?
AbstractEarly detection of nasopharyngeal carcinoma (NPC) is key to curing or improving the prognosis of this disease. Epstein–Barr virus (EBV) is an etiological factor for NPC, and as such, EBV and its expression products are also unique NPC biomarkers, since EBV rarely infects normal epithelial cells and EBV in NPC cells exhibits a different expression profile to that observed in persistently infected B cells. It is important to strategize the use of EBV serology and tests for plasma EBV DNA and the newly identified extracellular EBV microRNAs to optimize the sensitivity and specificity of NPC detection. Exploration of novel approaches, such as assessing methylation, telomere lengths, and circulating tumor cells, which are being used in other cancers, will provide additional advances in NPC detection and management. This chapter focuses on reviewing current diagnostic methods and discussing new strategies for using viral and cellular biomarkers for early recognition and management of NPC.
Persistent Identifierhttp://hdl.handle.net/10722/271901
ISBN

 

DC FieldValueLanguage
dc.contributor.authorChen, HL-
dc.contributor.authorJi, M-
dc.contributor.authorZong, JF-
dc.contributor.authorKo, JMY-
dc.contributor.authorDai, W-
dc.contributor.authorLung, ML-
dc.date.accessioned2019-07-20T10:31:41Z-
dc.date.available2019-07-20T10:31:41Z-
dc.date.issued2019-
dc.identifier.citationConventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma.. In Lee, A., Lung, M and Ng, W. (Eds.), Nasopharyngeal Carcinoma: Etiology to Clinical Practice, p. 129-153. London: Academic Press., 2019-
dc.identifier.isbn9780128149362-
dc.identifier.urihttp://hdl.handle.net/10722/271901-
dc.description.abstractEarly detection of nasopharyngeal carcinoma (NPC) is key to curing or improving the prognosis of this disease. Epstein–Barr virus (EBV) is an etiological factor for NPC, and as such, EBV and its expression products are also unique NPC biomarkers, since EBV rarely infects normal epithelial cells and EBV in NPC cells exhibits a different expression profile to that observed in persistently infected B cells. It is important to strategize the use of EBV serology and tests for plasma EBV DNA and the newly identified extracellular EBV microRNAs to optimize the sensitivity and specificity of NPC detection. Exploration of novel approaches, such as assessing methylation, telomere lengths, and circulating tumor cells, which are being used in other cancers, will provide additional advances in NPC detection and management. This chapter focuses on reviewing current diagnostic methods and discussing new strategies for using viral and cellular biomarkers for early recognition and management of NPC.-
dc.languageeng-
dc.publisherAcademic Press.-
dc.relation.ispartofNasopharyngeal Carcinoma: Etiology to Clinical Practice-
dc.subjectCirculating tumor cells-
dc.subjectct DNA-
dc.subjectDiagnosis-
dc.subjectEBV BART miRNAs-
dc.subjectEBV serology-
dc.titleConventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma.-
dc.typeBook_Chapter-
dc.identifier.emailKo, JMY: joko@hku.hk-
dc.identifier.emailDai, W: weidai2@hku.hk-
dc.identifier.emailLung, ML: mlilung@hku.hk-
dc.identifier.authorityKo, JMY=rp02011-
dc.identifier.authorityDai, W=rp02146-
dc.identifier.authorityLung, ML=rp00300-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/B978-0-12-814936-2.00007-9-
dc.identifier.hkuros298985-
dc.identifier.spage129-
dc.identifier.epage153-
dc.publisher.placeLondon-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats